Syndax Pharmaceuticals

Director, Regulatory Strategy

Syndax Pharmaceuticals$225K — $250K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in a scientific discipline; advanced scientific degree preferred (PharmD, Ph.D., MD).
  • 8+ years of pharmaceutical industry experience, including 5+ years in Regulatory Affairs leadership roles; global experience desired.
  • Innovator drug development experience in the US and EU/UK/EEA; experience in Asia PAC is a plus.
  • Proven 5+ years in a strategic leadership role with strong project management skills.
  • Experience directly interfacing with health authorities in major markets.

Responsibilities

  • Ensure the development and execution of regulatory strategies for assigned products/projects.
  • Act as a strategic partner for internal cross-functional stakeholders and external regulatory organizations.
  • Represent Syndax to regulatory health authorities, including the FDA.
  • Lead submission preparations for INDs, Briefing Documents, and Marketing Applications; collaborate with cross-functional teams.
  • Prepare the company team for health agency meetings as necessary.
  • Serve as the primary interface with Regulatory CROs for submission coordination.
  • Maintain current knowledge of the global regulatory environment and assess implications for the business.
  • Implement new processes and policies to enhance operational efficiency.

Benefits

  • Equity offering as part of the compensation package.
  • Annual target bonuses.
  • Comprehensive benefits program.
Full Job Description
Director, Regulatory Strategy

The Role:

The Director, Regulatory Strategy will be responsible for developing and implementing regulatory strategies to secure global investigational and marketing applications for assigned product(s) in the assigned therapeutic area. Leads the Product Regulatory Sub team. Ensures strategic messaging and content of global regulatory dossiers. May serve as the primary regulatory interface with the Asset Strategy Team and sub teams. Proactively anticipates and mitigates regulatory risks. Ensures compliance with global regulatory requirements. Manages assets through all phases of development from pre-FIH through active life cycle management activities. Demonstrates an understanding of drug development and exhibits leadership behaviors consistent with level. Has direct experience with regulatory acceleration strategies, developing regulatory strategy, analyzing regulatory precedence and operational excellence in execution of regulatory strategy. This role may lead a team of regulatory professionals.

Key Responsibilities:
  • Ensure the development and flawless execution of regulatory strategies for the assigned products/projects.
  • Strategic partner for internal cross functional stakeholders both within and external to the regulatory organization..
  • Represents Syndax to regulatory health authorities, e.g. FDA, for all products and businesses.
  • Lead the preparation of submissions, which may include INDs, Briefing Documents, Orphan Drug Applications, and Marketing Applications, etc. Work with cross-functional groups to define contributions to submissions. Lead regulatory submission teams for projects assigned.
  • Prepare company team for health agency meetings, as required.
  • Serve as the primary interface with Regulatory CROs for coordination and preparation of submissions.
  • Responsible for maintaining a working knowledge of the global regulatory environment in relevant disease areas and identify and communicate the implications of identified regulatory trends that may impact the business.
  • Maintain knowledge of global competitive landscape, regulatory environment, regulations and guidance.
  • Prepare, plan and implement new processes and policies to improve efficiency of the Company.


Desired Experience/Education and Personal Attributes:
  • Bachelor's degree in scientific discipline; advanced scientific degree preferred (PharmD, Ph.D, MD).
  • Regulatory Affairs Certification is highly desirable.
  • 8+ years pharmaceutical industry experience, including 5+ years in Regulatory Affairs leadership roles; Global experience desired.
  • Requires innovator drug development experience in the US and EU/UK/EEA. Experience in Asia PAC, a plus.
  • Proven 5+ years in a strategic leadership role with strong project management skills.
  • Experience working in a complex and matrix environment.
  • Experience directly interfacing with health authorities in a major market.
  • Experience in multiple phases of development is required.
  • Experience in rare disease, immunology or oncology is highly desirable.
  • Knowledge of the drug development process and global submission process.
  • Knowledge of global regulatory guidance as they relate to the overall global regulatory strategy.
  • Cross functional partnering skills, team-oriented and ability to influence outcomes are necessary skills in the environment.
  • Excellent organizational, communication and time management skills needed to manage multiple ongoing projects simultaneously.
  • Experience working within corporate partnerships is a plus.
  • Must be able to innovate, analyze and solve problems with minimal supervision and attention to detail.


Location: Syndax's corporate office is in New York, NY.

Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $225,000 - $250,000.

#LI-Remote

About Syndax Pharmaceuticals

Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The company's lead product candidate, entinostat, is a selective HDAC inhibitor that has been evaluated in multiple clinical trials in combination with immune checkpoint inhibitors and targeted therapies. Syndax is also developing SNDX-5613, a highly selective and potent inhibitor of the Menin-MLL interaction, for the treatment of acute leukemias. The company is committed to improving the lives of cancer patients through the discovery and development of novel therapies.
Learn more about Syndax Pharmaceuticals
Size
59 employees
Market Cap
$1.6 billion
Industry
Net Income
-$73.1 million
Founded
2005
5 Year Trend
+158.1%
Revenue
$1.5 million
NASDAQ

Similar Jobs

More Jobs at Syndax Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Director, Regulatory Strategy jobs: